About OFI Italian Pharmaceutical
OFI Italian Pharmaceutical is a Healthcare company based in Bergamo (Italy) founded in 1946, and was acquired by Alto Partners in April 2019. Pharmaceutical products are manufactured by OFI Italian Pharmaceutical in Italy. OFI Italian Pharmaceutical offers products and services including Dietary Supplements and Medical Devices. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity in India is Ofi (India) Private Limited (U74140DL2013PTC251554).
Company details
OFI Italian Pharmaceutical was established in 1946 in Bergamo, Italy, within the pharmaceutical sector. Manufacturing operations are centered on producing medicinal products for healthcare applications. The companys activities are conducted from its Italian base, with an online presence maintained through the domain ofi.it. Focus remains on standard pharmaceutical production processes, supporting regional and potential international distribution needs.
- Headquarters Bergamo, Italy
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ofi.it
- Social LinkedIn
- Acquired by Alto Partners (Apr 2019)
- Legal Name Ofi (India) Private Limited
- Date of Incorporation 03 May, 2013
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹87,691
FY 2023
- Indian entity net profit₹87,232
FY 2023 · 99% margin
- Indian entity EBITDA₹87,560
FY 2023 · 100% margin
- InvestorsFuturimpresa
& 1 more
- Acquired byAlto Partners
(Apr 2019)
Associated legal entities of OFI Italian Pharmaceutical
OFI Italian Pharmaceutical operates through Ofi (India) Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ofi (India) Private Limited CIN U74140DL2013PTC251554 | Strike Off | 03 May 2013 | New Delhi, Delhi | ₹0.0 Cr | 4 | View details |
Products & Services of OFI Italian Pharmaceutical
OFI Italian Pharmaceutical offers a comprehensive portfolio of products and services, including Dietary Supplements and Medical Devices.
Dietary supplements are developed and manufactured by Officina Farmaceutica Italiana for third parties, ensuring nutritional conformity and quality in formulations
Medical devices are produced by Officina Farmaceutica Italiana through controlled processes to guarantee product efficacy and safety
Funding Insights of OFI Italian Pharmaceutical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of OFI Italian Pharmaceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2010 | Private Equity Round | β | β |
2 investors in total: 2 institutional.
Investors in OFI Italian Pharmaceutical
OFI Italian Pharmaceutical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Futurimpresa and Alto Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| futurimpresa.it | ||||
| altopartners.it |
Investor details for OFI Italian Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ofi (India) Private Limited (OFI Italian Pharmaceutical)
Ofi (India) Private Limited is the primary company behind OFI Italian Pharmaceutical. The board of Ofi (India) Private Limited currently have 4 directors; the longest-serving is Sanjiv Khurana, appointed in 2013. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Khurana DIN 00524231 | Director | 03 May 2013 | 13 yrs 6 mo | Ofi (India) Private Limited |
| Arjun Khurana DIN 00524276 | Managing Director | 03 May 2013 | 13 yrs 6 mo | Ofi (India) Private Limited |
| Roberto Rettani DIN 06530294 | Director | 13 Nov 2013 | 13 yrs | Ofi (India) Private Limited |
| Alberto Donati DIN 06524642 | Director | 13 Nov 2013 | 13 yrs | Ofi (India) Private Limited |
Financials of OFI Italian Pharmaceutical
Figures of Ofi (India) Private Limited, the primary company behind OFI Italian Pharmaceutical, for FY 2023. Revenue was ₹87,691. Net profit was ₹87,232 (99% margin). EBITDA was ₹87,560 (100% margin). Revenue has grown at a compounded annual rate of -40% over three years and -58% over five years.
- ₹87,691Revenue · FY 2023
- ₹87,232Net profit · 99% margin
- ₹87,560EBITDA · 100% margin
- ₹4.80 CrPaid-up capital
- -40%Revenue CAGR, 3 years
- -58%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ofi (India) Private Limited are on its company page.
Detailed financial statements for OFI Italian Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of OFI Italian Pharmaceutical
3 dated milestones of OFI Italian Pharmaceutical across 73 years, from founding to its latest funding, stage changes and deals.
- Founded OFI Italian Pharmaceutical is founded.
- Funding First funding round.
- Exit Acquired by Alto Partners.
Web traffic of OFI Italian Pharmaceutical
The website of OFI Italian Pharmaceutical (ofi.it) receives about 2.5K visits a month and ranks #9,486,814 among all websites worldwide, #7,688 in Biotechnology and Pharmaceuticals.
- Monthly visits2.5K
▲ 49.2% vs previous month
- Global rank#9,486,814
among all websites
- Category rank#7,688
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.7
- Average visit40 sec
- DevicesDesktop 44% Β· Mobile 56%
Websites whose visitors overlap most with OFI Italian Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ibi-lorenzini.it | 100% | 5.4K | #2,714,888 | View details | |
fidiapharma.it | fidiapharma.it | 93% | #2,360,346 | β | |
e-pharma.com | e-pharma.com | 92% | #10,389,578 | β | |
lfm.it | lfm.it | 92% | #4,023,486 | β | |
| biofarmagroup.com | 83% | 15.7K | #1,639,133 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 16 similar websites and full traffic analytics for OFI Italian Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OFI Italian Pharmaceutical
OFI Italian Pharmaceutical was founded in 1946 and raised its 1st funding round 64 years after it was founded.
OFI Italian Pharmaceutical is headquartered in Bergamo, Italy. It is registered at Bergamo, Lombardy, Italy.
The primary company behind OFI Italian Pharmaceutical, Ofi (India) Private Limited, reported revenue of βΉ87,691 for FY 2023.
OFI Italian Pharmaceutical was established in 1946 in Bergamo, Italy, within the pharmaceutical sector. Manufacturing operations are centered on producing medicinal products for healthcare applications. The companys activities are conducted from its Italian base, with an online presence maintained through the domain ofi.it. Focus remains on standard pharmaceutical production processes, supporting regional and potential international distribution needs.
OFI Italian Pharmaceutical offers Dietary Supplements and Medical Devices.
OFI Italian Pharmaceutical has 2 investors. Key investors include Futurimpresa, and Alto Partners.
OFI Italian Pharmaceutical operates through Ofi (India) Private Limited.
Yes. OFI Italian Pharmaceutical was acquired by Alto Partners in April 2019.
The legal entities of OFI Italian Pharmaceutical currently have 4 directors, including Sanjiv Khurana, Arjun Khurana, Roberto Rettani and others.
